Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa
about
Prevalence and clinical features of HIV and malaria co-infection in hospitalized adults in Beira, MozambiqueGlobal Molecular Epidemiology of Cryptococcus neoformans and Cryptococcus gattii: An Atlas of the Molecular TypesOptimal timing for antiretroviral therapy initiation in patients with HIV infection and concurrent cryptococcal meningitisFrequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.A quantitative structure-activity relationship study of anti-HIV activity of substituted HEPT using nonlinear models.Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in MalawiMalaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in TanzaniaA re-examination of the potential impact of preventive therapy on the public health problem of tuberculosis in contemporary sub-Saharan Africa.Robust substrate profiling method reveals striking differences in specificities of serum and lung fluid proteases.Macroevolutionary Immunology: A Role for Immunity in the Diversification of Animal life.Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsCharacteristics and predictors of death among hospitalized HIV-infected patients in a low HIV prevalence country: BangladeshThe independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.HIV/AIDS Clinical Manifestations and their Implication for Patient Clinical Staging in Resource Limited Settings in Tanzania.Incidence of serious morbidity in HIV-infected adults on antiretroviral therapy in a West African care centre, 2003-2008Virulence in malaria: an evolutionary viewpointUniversal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study.Trends in prevalence of selected opportunistic infections associated with HIV/AIDS in Uganda.Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda.The impact of HIV on presentation and outcome of bacterial sepsis and other causes of acute febrile illness in Gabon.Malaria and hiv in adults: when the parasite runs into the virus.Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systematic review and meta-analysis.Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort StudyTuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa.Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa.Impact of mating type, serotype, and ploidy on the virulence of Cryptococcus neoformansEvolution of Cryptococcal Antigen Testing: What is new?Incidence of Opportunistic Infections and the Impact of Antiretroviral Therapy Among HIV-Infected Adults in Low- and Middle-Income Countries: A Systematic Review and Meta-analysisHow a different look at latency can help to develop novel diagnostics and vaccines against tuberculosis.Efflux-mediated antifungal drug resistance.The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda.A case on streptococcal pneumonia associated with leptomeningitis, osteomyelitis and epidural abscess in a patient with AIDS.Clinical profile & predictors of poor outcome of adult HIV-tuberculosis patients in a tertiary care centre in north IndiaPharmacological significance of triazole scaffold.Treatment of acquired immunodeficiency syndrome with Chinese medicine in China: opportunity, advancement and challenges.Developing an evidence-based, preventive care package for persons with HIV in Africa.HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.HIV-associated Isospora belli infection: incidence and risk factors in the French Hospital Database on HIV.Impact of HIV infection on the haemostatic response during sepsis and malaria.
P2860
Q21034056-07B77942-4E40-4D3E-8D66-435661A60AFCQ21284793-0B4C4849-228E-4E11-81D0-9FA1C8922576Q24234402-306D6FC2-63AE-4E10-8392-97B299E225E8Q30379957-6C168220-96C4-41A7-BE8B-F95B3B440E63Q30448502-7C695DDD-7B06-4C10-A8F4-DD2BD6946BC2Q33588561-8A36BDD9-29D8-4F23-B0B9-0AFFFD37D27AQ33749682-CACDA6F9-62E6-49EE-A81F-35056141C837Q33813159-71933ACC-B857-4C5B-9307-6441CF454066Q33977518-0019F9F2-D5CF-4426-988D-FFC3AF3E5958Q34261452-134DCEE9-658E-4233-ABB3-C7820BB65575Q34516548-C5E3C4B6-86F6-4CFF-A7F1-2D47665F9B71Q34653573-C965957E-9613-481E-AFB8-7F3214417AB7Q34777433-07A1AAF3-34A0-422F-B9A8-FF9B7CE7E4A6Q35012921-804C3A9C-6907-4743-9B1E-5640FAA48FABQ35076875-C7C0C9B5-B16F-415B-9F97-1C3E3EBBD14DQ35213982-A5A28204-FC01-4E14-8E89-F9B8219D3120Q35396977-C1E1FFAE-95DC-4CFD-98D4-86F0F9191DE8Q35534405-26359705-F707-4EFD-A3FD-E577F3043D52Q35737444-22180E1D-411D-4DBD-BE8C-96FCDB1A8649Q35905515-F2E7A5E7-0B08-4680-A7AE-1962AB912E1DQ36033898-EFB76015-61A0-45AC-BA78-096100940867Q36128774-8A0EEDDA-1F81-49CB-8531-EB29429443F8Q36167708-F4E665F0-9B3A-4D47-ABDA-8AA6855814F7Q36543833-31935E5A-2793-40A4-AD55-D9B2FB10148CQ36556975-EC054176-DD72-41F7-80E5-B20A60C85480Q36600275-708774AD-03C7-4A74-9356-374C610285A5Q36747220-2DCDE19D-6AF1-4236-AE72-5B030C8EF937Q36873953-46D77474-D0FB-47A6-B830-C8EA76B3316CQ36948103-309F9D17-C123-406D-9E64-5C28A2754712Q36981662-0CCC1D4F-67EE-4191-9611-2648E5A45891Q37156645-A23F01FA-B5AA-4752-AA69-5375206F0391Q37316263-CFD9F6DA-DEB3-4ACB-AA91-B81E46C326FDQ37628869-E20C8D7E-2775-41A0-B6B9-8B46508EFAFAQ37715217-48F18AD8-D6E0-4228-B6C1-DDC5CDE04911Q37768161-BC99FAB9-E206-48A7-A514-FC3458E59A2EQ38124751-33966605-CCBB-4686-B80C-235F6D670E78Q38456034-C6FEDAD8-3231-4039-A12E-10E7C6B6A797Q39002151-5362B50E-D6B7-4040-BBB8-8B4B40957F0BQ39035882-97364B47-18AF-4D93-AC68-BDB850B9C4F8Q39089160-3625917F-E5C1-4CED-BD9C-964DA7E4758A
P2860
Review of Human Immunodeficiency Virus Type 1–Related Opportunistic Infections in Sub‐Saharan Africa
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@ast
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@en
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@nl
type
label
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@ast
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@en
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@nl
altLabel
Review of human immunodeficien ...... fections in sub-Saharan Africa
@en
prefLabel
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@ast
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@en
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@nl
P50
P3181
P356
P1476
Review of Human Immunodeficien ...... fections in Sub‐Saharan Africa
@en
P2093
Charles B. Holmes
P304
P3181
P356
10.1086/367655
P407
P577
2003-03-01T00:00:00Z